Le Ma1Jiajia Zong1Xiaowei Xun1
Xiaoming Hu1
Zejing Chen1Quanchao Zhang1
Mengxia Peng1
Botao Song2*
Haiyong Ao1*- 1Jiangxi Key Laboratory of Nanobiomaterials, School of Materials Science and Engineering, East China Jiaotong University, Nanchang, China
- 2Key Laboratory of Synthetic and Natural Functional Molecule of the Ministry of Education, College of Chemistry and Materials Science, Northwest University, Xi’an, Shaanxi, China
In this study, gentamicin loaded collagen I/hyaluronic acid multilayers modified titanium coating (TC-AA(C/H)6-G) was fabricated via a layer-by-layer (LBL) covalent immobilization method. The drug releasing properties of collagen I/Hyaluronic acid (Col-I/HA) multilayers and the effect of loaded gentamicin on the antibacterial properties and cytocompatibility of modified TC were investigated. The gentamicin release assay indicated that the Col-I/HA multilayers modified TC exhibited agreeable drug-loading amount (537.22 ± 29.66 µg of gentamicin) and controlled-release performance (240 h of sustained release time). TC-AA(C/H)6-G revealed satisfactory antibacterial activity and inhibited the colonization and biofilm formation of S. aureus. Fortunately, the functions of hMSCs on TC-AA(C/H)6-G did not affected by the loaded gentamicin, and TC-AA(C/H)6-G could improve the adhesion, proliferation and osteogenic differentiation of cells, as well as TC-AA(C/H)6. In vivo animal study indicated that TC-AA(C/H)6-G could effectively control intramedullary cavity infection caused by S. aureus and prevent bone destruction.
Introduction
Implant infection is one of the most serious complications of orthopedic surgery (Schierholz and Beuth, 2001). An infection rate of 1.5%–2.5% is reported after primary arthroplasty, while in revision surgery the infection rate is 3.2%–5.6% (Montanaro et al., 2011). More seriously, the infection rates of internal fixation in severe closed fractures and in open fractures are 3.6%–8.1% and high to 20%, respectively (Johnson et al., 2007). As well as lengthening the healing time of the wound, postoperative infection could damage the osseointegration and reduce the utilization efficiency of the implant.
The traditional approach to treat post-operative infection is that after removed the implant through a second surgery, emergent debridement is performed with systemic broad-spectrum antibiotics, and then a new material is implanted after the wound healed. Nevertheless, some surrounding normal tissue followed with inflammation could be removed during debridement, which increases the pain of the patient and prolongs the treatment time. More importantly, the systemic application require high doses of antibiotics, which could cause systemic side effects (Tan et al., 2012b). The topical drug sustained release system could overcome the above-mentioned defects well. The antibacterial agent is loaded into the implant, and release slowly in the local wound area to prevent the adhesion and growth of pathogenic bacteria around the implant (Sun et al., 2019; Chen et al., 2021; Li et al., 2022).
The topical sustained drug release system could effectively solve the defects of traditional drug methods with low efficiency and high toxicity. The drug release systems used for surface modification of titanium-based materials include calcium-phosphorus bioactive ceramics and bioactive macromolecules (Wang et al., 2017; Sandomierski et al., 2022). As one of the most widely used drug sustained-release carriers, collagen I (Col-I) has excellent biocompatibility, degradability, weak antigenicity (Liu et al., 2008; Li et al., 2018; Tripathi et al., 2021). Wachol-Drewek et al. (1996) implanted a gentamicin-loaded collagen sponge into abdominal rot, resulting in a high local gentamicin concentration and remission of infection, while the drug concentration in serum was very low. Hyaluronic acid (HA) is another favored drug-loaded bioactive polymer. Csapó et al. (2018) prepared hyaluronic acid-based colloidal drug delivery systems, which may be a potential candidate for controlled drug release of hydrophobic ketoprofen (KP) molecules. The hyaluronic acid-heparin hydrogel prepared by Bhakta et al. (2012) can control the release of active factor bone morphogenetic protein-2 (BMP-2).
In our previous work (Ao et al., 2013), the collagen I/hyaluronic acid multilayer composite film was constructed on the surface of the plasma sprayed porous titanium coating (TC) by using a layer-by-layer (LBL) covalent immobilization method, which improved biological properties of the titanium coating. The obtained multilayer composite film with a certain thickness may have satisfactory drug-loaded release properties. The intention of this study was to investigate the drug-loaded and controlled-release properties of the composite membrane-modified TC and gentamicin was used as the model drug. The antibacterial properties and cytocompatibility of the drug-loaded composite membrane-modified TC were also explored, as well as intramedullary nail infection model.
Materials and methods
Materials
Titanium coating on Ti alloy plates (Φ 10 mm × 2 mm) and rods (Φ 1.6 mm × 20 mm) (denoted as TC) were fabricated by vacuum plasma spraying (VPS, F4-VB, Sulzer Metco, Switzerland) (Xue et al., 2005). Simply, after sandblasting, fine titanium powder was sprayed, followed by coarse titanium powder. Col-I from calf bone with 80,000–100,000 Da of molecular weight was obtained from Saining Bioengineering Technology Co., Ltd, Tianjin, China. HA powder with 300,000 molecular weight was purchased from Bloomage Freda Biopharm Co., Ltd, Jinan, China.
Fabrication of gentamicin loaded Col-I/HA multilayers on titanium coating
Gentamicin loaded Col-I/HA multilayers modified titanium coating was fabricated by a LBL covalent immobilization technique given by our previous study (Ao et al., 2013). As shown in Figure 1, TC samples were immersed in 5 M NaOH at 80 °C for 12 h, followed by immersing in a boiling aminopropyltriethoxysilane (APS)/toluene solution for 12 h to silanization. Then, the silanized samples were dipped alternately into the gentamicin/Col-I solution (2 mg/ml of gentamicin and 1 mg/ml of Col-I) and gentamicin/HA solution (2 mg/ml of gentamicin and 1 mg/ml of HA) for 30 min, both included 2.5 mg/ml 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and 0.63 mg/ml N-hydroxysuccinimide (NHS). Each dipping process was followed by rinsing with deionized water. After repeating six cycles, the samples were dried under vacuum and denoted as TC-AA(C/H)6-G.
FIGURE 1. Schematic illustration of the fabrication of gentamicin loaded Col-I/HA multilayers on titanium coating via a LBL covalent immobilization technique.
Col-I/HA multilayers modified titanium coating (TC-AA(C/H)6) as control group was constructed by the LBL covalent immobilization technique. Gentamicin loaded alkali-treated titanium coating (denoted as TC-A-G) and gentamicin loaded Col-I modified titanium coating (denoted as TC-AAC-G) were also prepared to compare the ability of loading and releasing gentamicin. Alkali-treated TCs were immersed into 2 mg/ml gentamicin solution for 24 h at 4°C. As for TC-AAC-G, silanized samples were immersed into the gentamicin/Col-I solution (2 mg/ml of gentamicin and 1 mg/ml of Col-I) for 24 h at 4°C. The solution included 2.5 mg/ml EDC and 0.63 mg/ml NHS. The two obtained samples were both dried under vacuum.
Release of gentamicin
The release profile of gentamicin was detected according to literature (Popat et al., 2007). One piece of three gentamicin-loaded samples (TC-A-G, TC-AAC-G and TC-AA(C/H)6-G) were placed in centrifuge tubes containing 2 ml of phosphate buffered solution (PBS). Centrifuge tubes were placed in a 37°C incubator and shaken at 100 rpm. At time points of 0, 1, 2, 4, 8, 12, 24, 48, 72, 96, 120, 144, 168, 192, 216, and 240 h, all PBS was collected separately, then 2 ml of fresh PBS was added. The PBS collected at each time point was analyzed for cumulative gentamicin release by chemical reaction colorimetry. First, 2.5 g Phthalaldehyde (Sigma), 62.5 ml methanol (Sigma) and 3 ml 2-mercaptoethanol (Sigma) were added to 560 ml sodium borate solution. 50 μl of gentamicin/PBS solution, 50 μl of the reaction solution prepared above and isopropanol was added into a 96-well plate and incubated for 30 min at room temperature. Third, the absorbance value of samples can be measured at 332 nm. Finally, the exact content of gentamicin in PBS was obtained according to the gentamicin standard.
Zone of inhibition
1 × 108 colony forming unit (CFUs) in 200 μl S. aureus (ATCC 25923) suspensions were evenly plated onto tryptone soy agar (TSA), and one specimen of TC-A-G, TC-AAC-G and TC-AA(C/H)6-G was placed on the center of the TSA and then cultivated for 24 h at 37°C. The zone of inhibition (ZOI) was observed and their widths were measured as described in the literature (Ao et al., 2019).
The spread plate method
Three kinds of samples [TC, TC-AA(C/H)6 and TC-AA(C/H)6-G] were incubated with 1 ml of bacterial suspension containing 1 × 106 CFU/ml for 6 h and 24 h. The bacteria adherent to the samples were collected using ultrasonication at the specific time points. After serial dilution by tenfold, bacteria suspensions were plated onto tryptone soy agar (TSA) for 24 h. The number of bacterial colonies on the substrates were counted and calculated.
Observation of bacteria by SEM and CLSM
The bacteria/material samples were obtained as stated above. After the samples were fixed in 2.5% glutaraldehyde solution, the bacteria/material specimens were dehydrated using a series of graded ethanol solutions. Then, the samples were observed through a scanning electron microscope (SEM, JEOL JSM-6700F, Japan).
After incubation with three strains for 6 h or 24 h, the materials with colonized bacterial were stained by LIVE/DEAD backlight bacteria viability kits, and then, they were observed with a confocal laser scanning microscope (CLSM, Leica TCS SP2; Leica Micro Systems, Germany).
Cell attachment and proliferation
The adhesion and proliferation behavior of human mesenchymal stem cells (hMSCs) on the material surface were detected by 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay according to the procedure described in literature (Ao et al., 2014). Among them, the cell concentration of the adhesion experiment was 5×104 cells/well, and the time points were 6, 12, and 24 h. While the cell concentration of the proliferation experiment was 1×104 cells/well, and the time points were 1, 3, and 6 days. In the proliferation assay, the optical density (OD) value at day 1 was measured as a baseline. The proliferation of hMSCs was expressed as the ratio of the OD value relative to the value for day 1 of the same specimen.
Osteogenic differentiation
Cells were seeded on materials surface at a density of 5×104 cells/well and co-cultured in the osteogenic induction medium for 4, 7 and 14 days. At each defined time point, the alkaline phosphatase activity of the cells on the surface of the material was compared using the quantitative method of pNPP, as described in the literature (Nie et al., 2016). Other cell/material specimens co-cultured in the osteogenic induction medium for 14 days were stained with alkaline phosphatase (ALP) to qualitatively display the osteogenic differentiation of the cells.
After 21 days of co-culture in the osteogenic induction medium, the osteogenic differentiation of cells was also observed by alizarin red staining. Briefly, after fixed with 95% ethanol for 10 min, cell/material specimens were dyed in 0.1% alizarin red solution at 37°C for 45 min, followed by dried and photographed (Nikon D90, Japan). Quantitative analysis of alizarin red staining as follows: The surface of the above-mentioned alizarin red-stained material was dissolved in 10% cetylpyridinum chloride (CPC) (Sigma-Aldrich) in sodium phosphate (pH = 7), and then the absorbance value (OD value) was measured on a microplate reader (Bio-tek, United States) at a wavelength of 620 nm (Yang et al., 2016).
Surgical procedures
Thirty 5-month-old female Sprague-Dawley rats that were randomly assigned to three groups were used. The use of animals and the experimental protocol were approved by the Animal Experimental Ethics Committee of East China Jiaotong University. After general anesthesia and sterilization, a hole with a diameter of 1.6 mm and depth of 20 mm was drilled through cortical and cancellous bone to access the medullary cavity. After injected 104 CFU of ATCC 25923, three implants (TC, TC-AA(C/H)6 and TC-AA(C/H)6-G) were inserted into the holes. All animals were tested on the day of surgery (day 0) and on the 1st, 3rd, 5th, 7th, 14th, 28th, 35th, and 42nd day after the operation. Ear temperature was measured by a digital infrared thermometer (TERUMO, Zhejiang, China) and animals were weighed with an electronic balance (TCS, Shanghai, China). Other observed indicators included left knee joint swelling and wound exudation. Animals were euthanized after 6 weeks, and the femurs with the implants were aseptically harvested. Five femurs were dissected longitudinally symmetrically along the midline of the femur and sored according to the scoring methods introduced in literature (Ao et al., 2019).
Microbiological evaluations
The removed implants were rolled on a TSA plate and incubated at 37°C for 24 h. The bacterial growth morphology of the TSA plate was photographed. On the other hand, the number of bacteria colonized on other removed implants and bones were investigated by the spread plate method. Specially, the femurs of each group were weighed, and then the quantity of bacteria in each bone was expressed relative to the femur weight (CFUs/g).
Radiographic evaluations
Femur and knee joint lateral radiographs of all groups were obtained on 1st, 21st, and 42th day post-surgery. Radiographic manifestations were assessed with a scoring system previously detailed in the literature (Peng et al., 2015).
Five femurs with implant in each group were randomly chosen. After the femurs were fixed with the 4% v/v buffered formaldehyde, all femurs that were collected were evaluated by micro-CT (SCANCO MEDICAL, μCT 80, CH-8306 Bruttisellen, Switzerland). 3D high-resolution images were obtained from overall, longitudinal and transverse sections. Bone volume/total volume (BV/TV) and the cortical bone mineral density (BMD) of the samples were reconstructed and analyzed.
Bone histopathology
After fixed in 4% v/v buffered formaldehyde for 48 h and decalcified for 2 weeks using a Rapid Decalcifier (DeCa DX-1000, Pro-Cure Medical Technology Co. Ltd., Hong Kong), medial femur halves were embedded in paraffin and sectioned using a microtome (CUT 6062; SLEE, Medical, Germany) to obtain 5 μm longitudinal and transverse sections. Hematoxylin and eosin (H&E) staining was used to assess morphology, and Giemsa staining was used to assess bacterial contamination. The pathological of bone tissue infection was quantitatively scored by the following indicators, intraosseous acute inflammation (IAI), intraosseous chronic inflammation (ICI), periosteal inflammation (PI) and bone necrosis (BN) (Nie et al., 2017).
Statistical analysis
Experiments were repeated five times for each sample. Statistical analysis was performed with SPSS software. Results were expressed as the mean ± standard deviation. Statistical significance was determined if p < 0.05.
Results and discussion
Release of gentamicin
Figure 2 shows the SEM of samples and the drug loaded amount and cumulative release curves of gentamicin of three drug-loaded modified titanium coatings. The gentamicin loaded amount of TC-AA(C/H)6-G was 537.22 ± 29.66 µg, higher than that of TC-A-G (299.96 ± 34.66 µg) and TC-AAC-G (420.02 ± 33.86 µg), because of the favourable drug loading properties of Col-I and HA (Figure 2B). It can be seen that burst release occurred in the release curve of TC-A-G, with the vast majority of loaded gentamicin released within 48 h. In contrast, the release time of gentamicin for TC-AAC-G and TC-AA(C/H)6-G was longer than that of TC-A-G, up to 168 h and 240 h, respectively (Figure 2C). As shown in our previous study (Ao et al., 2014), after alkali-treated, a microporous structure and abundant of Ti-OH groups were formed on the surface of titanium coating, which could be loaded with drugs. However, the micropores formed by alkali treatment were interconnected and had open porous structure, and do not have a controlled release effect. Many literatures have proved that both type I collagen and hyaluronic acid have excellent drug-loaded release properties (Ray et al., 2013; Ioan et al., 2019; Bayer, 2020). Compared with TC-A-G, TC-AAC-G can load more drugs and has a better sustained release effect due to the grafted collagen. Nevertheless, compared with TC-AAC-G, a composite membrane could be seen on the surface of TC-AA(C/H)6-G, which completely covered with porous and spicules structures produced by alkali treatment (Figure 2A). The composite membrane with considerable thickness endowed the TC-AA(C/H)6 with decent drug-loading and controlled-release performance, as shown in Figures 2A,B.
FIGURE 2. SEM of samples (A), Drug loaded amount (B) and cumulative release curves of gentamicin (C) of TC-A-G, TC-AAC-G and TC-AA(C/H)6-G.
Zone of inhibition
The zone of inhibition for the three drug-loaded titanium coatings are shown in Figure 3. At the same time point, the ZOI of TC-AA(C/H)6-G was larger than that of TC-A-G and TC-AAC-G. The reason might be that TC-AA(C/H)6-G could releases more gentamicin per unit time than TC-A-G and TC-AAC-G, which could kill bacteria in a wider range and form the larger bacteriostatic ring. On the other hand, the inhibition rings of TC-A-G and TC-AAC-G disappeared on the 5th day, while the inhibition rings of TC-AA(C/H)6-G persisted until the 7th day. This result was because of the better sustained-release properties of TC-AA(C/H)6-G, and indicated that TC-AA(C/H)6-G had improved sustained antibacterial ability compared with TC-A-G and TC-AAC-G.
FIGURE 3. The zone of inhibition (ZOI) of multilayer membrane modified TCs loading gentamycin. (A) The ZOI against S. aureus produced by different specimens at different time points; (B) The ZOI diameters of all specimens.
Antibacterial properties
To investigate the bacteriostatic rate of TC-AA(C/H)6-G, the spread plate method was employed and the results were shown in Figure 4A. The number of bacteria on the surface of TC-AA(C/H)6-G was much less than that of TC and TC-AA(C/H)6 at both time points (6 h and 24 h), indicating that the sample TC-AA(C/H)6 could inhibit bacterial colonization and biofilm formation. After counting and calculating, the bacteriostatic rate of TC-AA(C/H)6-G was 94.3 ± 2.5% at 6 h, and 99.8 ± 0.2% at 24 h. We also noticed that the bacteriostatic rate of TC-AA(C/H)6 was also 42.5 ± 3.2% at 6 h (Table 1). This might be because hyaluronic acid has a certain anti-bacterial adhesion ability. Pirnazar et al. (1999) found that hyaluronic acid could inhibit bacterial adhesion and reproduction but had no bactericidal effect. Drago et al. (2014) also reported that hyaluronic acid was able to interfere with bacterial adhesion to a cellular substrate in a concentration dependent manner. After 24 h of incubation, the bacteriostatic rate of TC-AA(C/H)6 was only 15.3 ± 2.6%, which meant there was basically no bacteriostatic effect (Table 1).
TABLE 1. The bacteriostatic rate of samples compared with TC.
FIGURE 4. Antibacterial properties of TC-AA(C/H)6-G. (A) Bacterial colonization and biofilm formation by the spread plate method; (B) SEM of bacteria on the three different specimens after incubated 6 h and 24 h; (C) The CLSM views of bacterial colonization and biofilm formation on the three kinds of samples, green for living bacteria and red for dead bacteria.
The fabulous antibacterial activities of TC-AA(C/H)6-G was further verified by SEM and CLSM. As shown in Figure 4B, the surfaces of TC and TC-AA(C/H)6 had colonized a large number of bacteria at 6 h, and a thick biofilm was formed on their surface at 24 h. Bacteria were hardly found on the surface of TC-AA(C/H)6-G at both time points. From the view of CLSM, most of bacteria on TC-AA(C/H)6-G were dead (red), meaning that bacteria colonized on its surface could be killed by gentamicin. Nearly all bacteria on TC and TC-AA(C/H)6 were alive (green) due to the lack of germicidal ability (Figure 4C).
Cytocompatibility
Figure 5A shows the adhesion of hMSCs on the surfaces of TC, TC-AA(C/H)6 and TC-AA(C/H)6-G. The number of hMSCs on TC-AA(C/H)6 and TC-AA(C/H)6-G was higher than that on TC at all the specified time points. Especially at 12 h, there was a significant difference between TC and the other two. But there is no significant difference between TC-AA(C/H)6 and TC-AA(C/H)6-G. The results of the adhesion experiment indicated that the Col-I/HA composite membrane constructed on TC, could promote the adhesion of cells, which was not affected by the loaded gentamicin.
FIGURE 5. Cytocompatibility of TC, TC-AA(C/H)6 and TC-AA(C/H)6-G. (A) Attachment of hMSCs on three different samples; (B) Proliferation of hMSCs on three different samples; (C) ALP activity was measured using the pNPP assay and normalized based on the protein content per specimen at days 4, 7 and 14; (D) Colorimetric quantitative analysis of the extracellular matrix mineralization on the samples after 21 days of incubation; (E) ALP staining was performed at day 14; (F) Alizarin red staining. *p < 0.05, there has significant difference between TC-AA(C/H)6-G and TC. #p > 0.05, there has no significant difference between TC-AA(C/H)6-G and TC-AA(C/H)6.
Figure 5B shows the proliferation of hMSCs on the surface of TC, TC-AA(C/H)6, and TC-AA(C/H)6-G. To eliminate the influence of adhesion differences on the proliferation results, the OD value on day 1 was used as the benchmark, and the proliferation rate of other time points relative to the benchmark was used to represent the proliferation rate of cells on samples (Tan et al., 2012a). As can be seen from the results, the proliferation rate of TC-AA(C/H)6-G was significantly higher than that of TC, but showed no significant difference compared with that of TC-AA(C/H)6. The results indicated that TC-AA(C/H)6-G could promote cell proliferation as well as TC-AA(C/H)6.
The osteogenic differentiation of hMSCs on different samples had also been investigated. The quantitative determination of ALP activity was shown in Figure 5C. ALP expression of group TC-AA(C/H)6 and TC-AA(C/H)6-G was significantly higher than TC at all time points. In particular, the ALP expression of group TC-AA(C/H)6-G was lower than that of group TC-AA(C/H)6 on day 7 and 14, but the difference between them was not statistically significant. The images of ALP staining performed on day 14 further showed the stronger ALP positivity of hMSCs on TC-AA(C/H)6 and TC-AA(C/H)6-G compared with TC (Figure 5E). On day 21 after osteogenic induction, calcium nodules generated by cells were stained red by alizarin red. Clearly, the calcium nodules on TC-AA(C/H)6 and TC-AA(C/H)6-G were manifestly more than that on TC (Figures 5D,F). ALP is an enzyme expressed by mesenchymal stem cells during osteogenesis and a well-defined marker for their differentiation, while calcium deposition is critical factors for mineralization of cells and bone-implant interfacial osteointegration (Bai et al., 2020). The results of ALP activity analysis and alizarin red staining demonstrated that TC-AA(C/H)6-G could significantly promote the osteogenic differentiation and mineralization of hMSCs.
The condition of the animals during the experiment
Figure 6 showed the changes in body temperature and weight of animals after operation. The body temperature of all animals was between 37.45 and 37.60, which remained normal during the experimental observation period. The animal weight of TC and TC-AA(C/H)6 groups increased slightly during the first 3 days, following by decreased and reached the lowest point on the 15th day, which was influenced by the infection. On the other hand, the animal weight of TC-AA(C/H)6-G group was not affected by the injected bacteria and increased steadily during the follow-up period. During the follow-up period, no obvious systemic complications occurred in all animals. Most of the animals in the TC and TC-AA(C/H)6 groups had swelling symptoms in the left knee joint, and the left lower limb in the TC-AA(C/H)6-G experiment was normal.
FIGURE 6. Postoperative changes in temperature (A) and weight (B) of animals.
Gross appearance of femurs
Longitudinal sections of femurs were shown in Figure 7A. The femurs of group TC and TC-AA(C/H)6 appeared noticeable purulent infection lesions, including the formation of intramedullary pus, osteolytic lesions and periosteal reaction. While no infection lesion was found in the TC-AA(C/H)6-G group. For the gross pathological scores of animal specimens, the scores of TC, TC-AA(C/H)6 and TC-AA(C/H)6-G were 3.24 ± 0.95, 2.92 ± 0.88, and 0.83 ± 0.51, respectively (Figure 7B). The score of the TC-AA(C/H)6-G group was significantly lower than that of the other two groups (*p < 0.05). From the results of gross appearance of femurs, it could be preliminarily concluded that the TC-AA(C/H)6-G group inhibited the intramedullary cavity infection caused by S. aureus.
FIGURE 7. -Gross appearance and scores of longitudinal sections of three kinds of femurs. (A) TC and TC-AA(C/H)6 groups showed signs of purulent infections, while the TC-AA(C/H)6-G group showed no obvious infection signs; (B) The score of the TC-AA(C/H)6-G group was significantly lower than other two groups, *p < 0.05.
Microbiological evaluation
Figure 8A showed the results of growth of bacterial colonies of implants on TSA. There was a large amount of bacterial colonized on implant TC and TC-AA(C/H)6, while only a few bacterial colonies could be found on implant TC-AA(C/H)6-G. The results of quantitative analysis also showed that the bacteria on implant TC-AA(C/H)6-G (3.6 ± 0.95 × 104 CFU) were evidently less than that on implant TC (1.62 ± 0.26 × 106 CFU) and TC-AA(C/H)6 (1.58 ± 0.19 × 106 CFU) (Figure 8B). Coincidentally, the bacterial count of femoral tissue of group TC-AA(C/H)6-G was significantly lower than that of group TC and TC-AA(C/H)6 (Figure 8C).
FIGURE 8. Quantification of bacteria obtained from explanted implants and bone tissue on day of sacrifice. (A) Growth of bacterial colonies of implants on TSA; (B) The number of CFU per implant; (C) Amount of CFU per gram of bone. *p < 0.05 compared with TC-AA(C/H)6-G and other two groups.
Radiographic evaluation
Figure 9A shows the X-ray imaging analysis at three postoperative time points. As for TC and TC-AA(C/H)6 groups, osteolysis and periosteal reactions around the distal femurs were observed obviously after 3 weeks, osteosclerosis and deformities were also evident after 6 weeks post-surgery. Conversely, no obvious imaging signs of bone infection were found in the TC-AA(C/H)6-G group at the selected time points. The results of quantitative imaging analysis were shown in Figure 9C. In the TC and TC-AA(C/H)6 groups, radiographic scores gradually increased after surgery, whereas in the TC-AA(C/H)6-G group, there was no clearly visible improvement. At 3rd week and 6th week, the statistical score of the TC-AA(C/H)6-G group was significantly lower than that of the TC and TC-AA(C/H)6 groups.
FIGURE 9. (A) X-ray photograph of left femur in lateral view 1 day, 3 and 6 weeks after operation. Typical signs include osteolytic lesions (black arrowhead) and periosteal new bone formation (white arrowhead); (B) 3D images of overall, longitudinal and transverse sections; (C) Quantitative analysis of the X-ray images; (D) the cortical one mineral density (BMD) of ROI; (E) bone volume/total volume (BV/TV) of ROI. *p < 0.05 compared with TC-AA(C/H)6-G and other two groups.
The radiographic observations mentioned above were confirmed by micro-CT analyses. As seen from Figures 9A,B, a significant amount of damage to the compact bone in both TC and TC-AA(C/H)6 groups, while the femoral cortical bones were intact in the TC-AA(C/H)6-G group. The BMD of the interest region of the TC-AA(C/H)6-G group was 939.63 ± 90.52 mg/ccm. Because of infection, the BMD of the interest region of the TC and TC-AA(C/H)6 groups decreased to 689.86 ± 55.67 mg/ccm and 683.22 ± 60.48 mg/ccm, respectively (Figure 9D). The bone volume fraction of the interest region in the TC-AA(C/H)6-G group was 88.04 ± 8.32%, which was significantly higher than 66.43 ± 9.12% in the TC group and 66.95 ± 8.54% in the TC-AA(C/H)6 group (Figure 9E).
Bone histopathology
The morphological change on the left femur was assessed by H&E staining (Figure 10A), and the bacterial residue was confirmed by Giemsa staining (Figure 9B). In the TC and TC-AA(C/H)6 groups, there was obvious destruction of cortical bone, which was accompanied by intracortical abscesses, inflammatory cell infiltration, and medullary sequestrum formation. Many bacteria could be observed within the cavities of damaged cortical bone from the Giemsa staining. Whereas, there was no evident bone destruction only relatively slight inflammatory cell infiltration in the TC-AA(C/H)6-G group. Meanwhile, there were few bacteria can be found in the intramedullary cavities of the TC-AA(C/H)6-G group (Figure 10B). The results also indicated that the invasive bacteria have been inhibited by gentamicin, as shown in the literature (Nie et al., 2022).
FIGURE 10. Representative photomicrographs of longitudinal sections of femurs. (A) H&E staining; (B) Giemsa staining.
Conclusion
In summary, gentamicin loaded Col/HA multilayers modified titanium coatings has been prepared by LBL covalent immobilization method. The Col-I/HA multilayer thin film modified on TC exhibited agreeable drug-loading capacity (537.22 ± 29.66 µg) and controlled-release performance compared with TC-A and TC-AAC. The slow release of gentamicin endowed TC-AA(C/H)6-G satisfactory and sustained antibacterial properties with inhibition to the colonization and biofilm formation of S. aureus, while the Col/HA multilayers improved cytocompatibility of TC-AA(C/H)6-G and promoted the adhesion, proliferation and osteogenic differentiation of hMSCs. Furthermore, TC-AA(C/H)6-G inhibited intramedullary cavity infection caused by S. aureus.
Data availability statement
The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.
Ethics statement
The animal study was reviewed and approved by the Animal Ethics Committee of East China Jiaotong University.
Author contributions
LM: Formal analysis, Writing-original draft. JZ: Investigation, Formal analysis. XX: Investigation, Data curation. XH: Data curation, Funding acquisition. ZC: Writing-review and editing, Funding acquisition. QZ: Supervision, Funding acquisition. MP: Formal analysis. BS: Writing-review and editing, Supervision. HA: Conceptualization, Investigation, Funding acquisition, Resources, Writing-original draft, Writing-review and editing, Project administration.
Funding
This work is supported by the Natural Science Foundation of Jiangxi Provence (Grant Nos 20212ACB214002, 20212BAB214005, and 20212BAB204004), grant awarded by the National Natural Science Foundation of China (Grant Nos. 82160355, 22001069) and Science and Technology Research Project of Jiangxi Education Department (Grant No. GJJ200665).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Ao, H., Xie, Y., Tan, H., Yang, S., Li, K., Wu, X., et al. (2013). Fabrication and in vitro evaluation of stable collagen/hyaluronic acid biomimetic multilayer on titanium coatings. J. R. Soc. Interface 10, 20130070. doi:10.1098/rsif.2013.0070
Ao, H., Xie, Y., Tan, H., Wu, X., Liu, G., Qin, A., et al. (2014). Improved hMSC functions on titanium coatings by type I collagen immobilization. J. Biomed. Mater. Res. A 102, 204–214. doi:10.1002/jbm.a.34682
Ao, H., Yang, S., Nie, B. e., Fan, Q., Zhang, Q., Zong, J., et al. (2019). Improved antibacterial properties of collagen I/hyaluronic acid/quaternized chitosan multilayer modified titanium coatings with both contact-killing and release-killing functions. J. Mater. Chem. B 7, 1951–1961. doi:10.1039/c8tb02425a
Bai, J., Wang, H., Chen, H., Ge, G., Wang, M., Gao, A., et al. (2020). Biomimetic osteogenic peptide with mussel adhesion and osteoimmunomodulatory functions to ameliorate interfacial osseointegration under chronic inflammation. Biomaterials 255, 120197. doi:10.1016/j.biomaterials.2020.120197
Bayer, I. S. (2020). Hyaluronic acid and controlled release: A review. Molecules 25, 2649. doi:10.3390/molecules25112649
Bhakta, G., Rai, B., Lim, Z. X. H., Hui, J. H., Stein, G. S., van Wijnen, A. J., et al. (2012). Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2. Biomaterials 33, 6113–6122. doi:10.1016/j.biomaterials.2012.05.030
Chen, X., Gao, Y., Wang, Y., and Pan, G. (2021). Mussel-inspired peptide mimicking: An emerging strategy for surface bioengineering of medical implants. Smart Mater. Med. 2, 26–37. doi:10.1016/j.smaim.2020.10.005
Csapó, E., Szokolai, H., Juhász, Á., Varga, N., Janovák, L., and Dékány, I. (2018). Cross-linked and hydrophobized hyaluronic acid-based controlled drug release systems. Carbohydr. Polym. 195, 99–106. doi:10.1016/j.carbpol.2018.04.073
Drago, L., Cappelletti, L., De Vecchi, E., Pignataro, L., Torretta, S., and Mattina, R. (2014). Antiadhesive and antibiofilm activity of hyaluronic acid against bacteria responsible for respiratory tract infections. Apmis 122, 1013–1019. doi:10.1111/apm.12254
Ioan, D.-C., Rău, I., Tihan, G. T., Zgârian, R. G., Ghica, M. V., Albu Kaya, M. G., et al. (2019). Piroxicam-collagen-based sponges for medical applications. Int. J. Polym. Sci. 2019, 1–7. doi:10.1155/2019/6062381
Johnson, E. N., Burns, T. C., Hayda, R. A., Hospenthal, D. R., and Murray, C. K. (2007). Infectious complications of open type III tibial fractures among combat casualties. Clin. Infect. Dis. 45, 409–415. doi:10.1086/520029
Li, Z., Masumoto, H., Jo, J. I., Yamazaki, K., Ikeda, T., Tabata, Y., et al. (2018). Sustained release of basic fibroblast growth factor using gelatin hydrogel improved left ventricular function through the alteration of collagen subtype in a rat chronic myocardial infarction model. Gen. Thorac. Cardiovasc. Surg. 66, 641–647. doi:10.1007/s11748-018-0969-z
Li, M., Bai, J., Tao, H., Hao, L., Yin, W., Ren, X., et al. (2022). Rational integration of defense and repair synergy on PEEK osteoimplants via biomimetic peptide clicking strategy. Bioact. Mater. 8, 309–324. doi:10.1016/j.bioactmat.2021.07.002
Liu, B., Cai, S. X., Ma, K. W., Xu, Z. L., Dai, X. Z., Yang, L., et al. (2008). Fabrication of a PLGA-collagen peripheral nerve scaffold and investigation of its sustained release property in vitro. J. Mater. Sci. Mater. Med. 19, 1127–1132. doi:10.1007/s10856-007-3224-1
Montanaro, L., Speziale, P., Campoccia, D., Ravaioli, S., Cangini, I., Pietrocola, G., et al. (2011). Scenery of staphylococcus implant infections in orthopedics. Future Microbiol. 6, 1329–1349. doi:10.2217/fmb.11.117
Nie, B. e., Ao, H., Chen, C., Xie, K., Zhou, J., Long, T., et al. (2016). Covalent immobilization of KR-12 peptide onto a titanium surface for decreasing infection and promoting osteogenic differentiation. RSC Adv. 6, 46733–46743. doi:10.1039/c6ra06778f
Nie, B. e., Ao, H., Long, T., Zhou, J., Tang, T., and Yue, B. (2017). Immobilizing bacitracin on titanium for prophylaxis of infections and for improving osteoinductivity: An in vivo study. Colloids Surfaces B Biointerfaces 150, 183–191. doi:10.1016/j.colsurfb.2016.11.034
Nie, B. e., Huo, S., Qu, X., Guo, J., Liu, X., Hong, Q., et al. (2022). Bone infection site targeting nanoparticle-antibiotics delivery vehicle to enhance treatment efficacy of orthopedic implant related infection. Bioact. Mater. 16, 134–148. doi:10.1016/j.bioactmat.2022.02.003
Peng, Z., Ao, H., Wang, L., Guo, S., and Tang, T. (2015). Quaternised chitosan coating on titanium provides a self-protective surface that prevents bacterial colonisation and implant-associated infections. RSC Adv. 5, 54304–54311. doi:10.1039/c5ra07540h
Pirnazar, P., Wolinsky, L., Nachnani, S., Haake, S., Pilloni, A., and Bernard, G. W. (1999). Bacteriostatic effects of hyaluronic acid. J. Periodontol. 70, 370–374. doi:10.1902/jop.1999.70.4.370
Popat, K. C., Eltgroth, M., LaTempa, T. J., Grimes, C. A., and Desai, T. A. (2007). Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 28, 4880–4888. doi:10.1016/j.biomaterials.2007.07.037
Ray, N., van Noorden, T., Radu, F. A., Friess, W., and Knabner, P. (2013). Drug release from collagen matrices including an evolving microstructure. Z. Angew. Math. Mech. 93, 811–822. doi:10.1002/zamm.201200196
Sandomierski, M., Zielinska, M., Buchwald, T., Patalas, A., and Voelkel, A. (2022). Controlled release of the drug for osteoporosis from the surface of titanium implants coated with calcium titanate. J. Biomed. Mater. Res. 110, 431–437. doi:10.1002/jbm.b.34919
Schierholz, J. M., and Beuth, J. (2001). Implant infections: A haven for opportunistic bacteria. J. Hosp. Infect. 49, 87–93. doi:10.1053/jhin.2001.1052
Sun, Y., Zhao, Y.-Q., Zeng, Q., Wu, Y.-W., Hu, Y., Duan, S., et al. (2019). Dual-functional implants with antibacterial and osteointegration-promoting performances. ACS Appl. Mater. Interfaces 11, 36449–36457. doi:10.1021/acsami.9b14572
Tan, H., Guo, S., Yang, S., Xu, X., and Tang, T. (2012a). Physical characterization and osteogenic activity of the quaternized chitosan-loaded PMMA bone cement. Acta Biomater. 8, 2166–2174. doi:10.1016/j.actbio.2012.03.013
Tan, H., Peng, Z., Li, Q., Xu, X., Guo, S., and Tang, T. (2012b). The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus. Biomaterials 33, 365–377. doi:10.1016/j.biomaterials.2011.09.084
Tripathi, S., Singh, B. N., Divakar, S., Kumar, G., Mallick, S. P., and Srivastava, P. (2021). Design and evaluation of ciprofloxacin loaded collagen chitosan oxygenating scaffold for skin tissue engineering. Biomed. Mater. 16, 025021. doi:10.1088/1748-605x/abd1b8
Wachol-Drewek, Z., Pfeiffer, M., and Scholl, E. (1996). Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin. Biomaterials 17, 1733–1738. doi:10.1016/0142-9612(96)87654-x
Wang, T., Weng, Z., Liu, X., Yeung, K. W. K., Pan, H., and Wu, S. (2017). Controlled release and biocompatibility of polymer/titania nanotube array system on titanium implants. Bioact. Mater. 2, 44–50. doi:10.1016/j.bioactmat.2017.02.001
Xue, W. C., Liu, X. Y., Zheng, X. B., and Ding, C. X. (2005). In vivo evaluation of plasma-sprayed titanium coating after alkali modification. Biomaterials 26, 3029–3037. doi:10.1016/j.biomaterials.2004.09.003
Keywords: titanium coatings, Col-I/HA multilayers, drug-release, prevention infection, cytocompatibility
Citation: Ma L, Zong J, Xun X, Hu X, Chen Z, Zhang Q, Peng M, Song B and Ao H (2022) Fabrication of gentamicin loaded Col-I/HA multilayers modified titanium coatings for prevention of implant infection. Front. Chem. 10:1019332. doi: 10.3389/fchem.2022.1019332
Received: 15 August 2022; Accepted: 10 November 2022;
Published: 22 November 2022.
Edited by:
Weicheng Hu, Huaiyin Normal University, ChinaReviewed by:
Guoqing Pan, Jiangsu University, ChinaEnhui Zhang, Lanzhou Institute of Chemical Physics (CAS), China
Copyright © 2022 Ma, Zong, Xun, Hu, Chen, Zhang, Peng, Song and Ao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Botao Song, Ym90YW9zb25nQG53dS5lZHUuY24=; Haiyong Ao, YW9oeW9uZ0AxMjYuY29t